Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
AstraZeneca
Cipla
Teva
Federal Trade Commission
Daiichi Sankyo
Cantor Fitzgerald
QuintilesIMS
Argus Health
Julphar

Generated: February 23, 2018

DrugPatentWatch Database Preview

CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic sources for chlorpheniramine maleate; phenylpropanolamine hydrochloride and what is the scope of chlorpheniramine maleate; phenylpropanolamine hydrochloride patent protection?

Chlorpheniramine maleate; phenylpropanolamine hydrochloride
is the generic ingredient in three branded drugs marketed by Graham Dm and Novartis, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for chlorpheniramine maleate; phenylpropanolamine hydrochloride.
Summary for CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE

US Patents and Regulatory Information for CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis TRIAMINIC-12 chlorpheniramine maleate; phenylpropanolamine hydrochloride TABLET, EXTENDED RELEASE;ORAL 018115-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Graham Dm COLD CAPSULE IV chlorpheniramine maleate; phenylpropanolamine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018793-001 Apr 25, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Graham Dm COLD CAPSULE V chlorpheniramine maleate; phenylpropanolamine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 018794-001 Apr 23, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
McKinsey
Covington
Baxter
Accenture
Fish and Richardson
Boehringer Ingelheim
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot